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Background: The aim was to investigate possible associations between glioma (an aggressive type of brain cancer)
and occupational exposure to selected agents: combustion products (diesel and gasoline exhaust emissions, benzo
(a)pyrene), dusts (animal dust, asbestos, crystalline silica, wood dust) and some other chemical agents
(formaldehyde, oil mist, sulphur dioxide).
Methods: The INTEROCC study included cases diagnosed with glioma during 2000–2004 in sub-regions of seven
countries. Population controls, selected from various sampling frames in different centers, were frequency or
individually matched to cases by sex, age and center. Face-to-face interviews with the subject or a proxy
respondent were conducted by trained interviewers. Detailed information was collected on socio-economic and
lifestyle characteristics, medical history and work history. Occupational exposure to the 10 selected agents was
assessed by a job exposure matrix (JEM) which provides estimates of the probability and level of exposure for
different occupations. Using a 25% probability of exposure in a given occupation in the JEM as the threshold for
considering a worker exposed, the lifetime prevalence of exposure varied from about 1% to about 15% for the
different agents. Associations between glioma and each of the 10 agents were estimated by conditional logistic
regression, and using three separate exposure indices: i) ever vs. never; ii) lifetime cumulative exposure; iii) total
duration of exposure.
Results: The study sample consisted of 1,800 glioma cases and 5,160 controls. Most odds ratio estimates were close
to the null value. None of the ten agents displayed a significantly increased odds ratio nor any indication of
dose–response relationships with cumulative exposure or with duration of exposure.
Conclusion: Thus, there was no evidence that these exposures influence risk of glioma.
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Brain tumors constitute a mixed group of intracranial
neoplasms which could be benign or malignant. Gliomas
account for almost 80% of primary malignant brain
tumours [1]. Of the six major histological subtypes of
glioma, glioblastoma constitutes the highest grade and the
most common type, and is associated with very poor sur-
vival [1,2]. The incidence of glioma differs according to
age, gender, race, ethnicity and country; in many regions
slight increases have been reported between the 1970s and
2000, though it is unclear whether this ostensible increase
simply reflected diagnostic improvement [3].
Except for ionizing radiation, which is a well-established
risk factor for glioma [4,5], the aetiology of this tumor is
largely unknown [4,6,7]. Some case–control studies have
found a lower risk of glioma among subjects reporting al-
lergies or other atopic conditions [4]. There is inconsistent
and largely negative evidence regarding possible associa-
tions between smoking, diet or alcohol and gliomas [3,4].
Concerns have been raised about possible effects of expos-
ure to non-ionizing radiation including radiofrequency
(RF) fields due to mobile phones or electromagnetic fields
(EMF) in the extremely low frequency range (ELF), but
the evidence remains inconsistent and uncertain [8-12].
A few studies have reported on glioma risks in relation
to occupations or industries, but there has not been any
strong consistent pattern across studies. Slight increased
risks have been reported among workers in synthetic
rubber manufacturing [13], petrochemical refineries [14]
and pulp and paper industries [15], as well as among
physicians [14,16,17], firefighters [14,17], farmers [16,18]
and legal and social services workers [14]. More studies
have reported on occupational risks for all brain cancers
combined [18-20]. There have been reports of increased
risk of brain tumors for polyvinyl chloride production
workers [21,22], anatomists, pathologists and embalmers
[23-25], painters, machinists, industrial mechanics and
plumbers [26,27]. Few studies have delved into the
possible associations between specific occupational ex-
posures in those occupations/industries and the risk of
brain cancer. There is a need for studies that go beyond
the job or industry title to investigate brain cancer risks
in relation to chemical exposures.
The INTEROCC study was built on two important
databases: the INTERPHONE study, the largest inter-
national collaborative case–control study of brain cancer
yet conducted [28], and FINJEM, a database permitting
the translation of job histories into occupational exposure
histories [29]. The INTERPHONE study involved inter-
views with over 2,400 meningioma cases, 2,700 glioma
cases and over 5,600 controls in regions of 13 countries,
with a primary focus on use of mobile phones. A subset of
INTERPHONE study investigators were interested in
investigating occupational risk factors and had agreed toinclude in the interview questionnaire a module to elicit a
detailed lifetime job history. That module was used in
seven of the INTERPHONE countries, and the subjects in
those countries comprise the INTEROCC study subjects.
No further data collection was required from the study
subjects. The second pillar for this project, the FINJEM,
allowed us to infer exposure to many occupational agents.
Following examination of the agents that were available
in FINJEM, and a review of previous epidemiologic evi-
dence concerning occupations and brain cancer risk, we
established a list of 28 agents that would be worthwhile to
evaluate in relation to brain cancer. These 28 substances
comprised solvents, metals, combustion products, dusts
and other chemical agents. For most of them there is little
epidemiologic evidence, and little or no literature on
possible mechanisms of brain cancer carcinogenesis. This
should not be an impediment to studies such as the
present one, since most known carcinogens were disco-
vered by epidemiologic or clinical observation, before there
were evidence-based biological plausibility arguments [30].
The present article focuses on risks of glioma in relation to
10 of the agents, namely combustion products (diesel
exhaust emissions, gasoline exhaust emissions, benzo(a)
pyrene), dusts (asbestos, crystalline silica, wood dust, animal
dust) and certain other chemical agents (formaldehyde,
oil mist, sulphur dioxide). Subsequent papers will address
risks related to other agents and to meningioma.
Methods
The INTERPHONE study
INTERPHONE was a population-based case–control study
of brain cancer carried out in 17 centers in regions of 13
countries [8,28]. The main purpose was to investigate pos-
sible associations with use of mobile phones. For most cen-
ters, eligible cases were all patients aged between 30 and
59 years and diagnosed with a glioma or meningioma
tumor between 2000 and 2004. In Germany and the UK,
the upper age limit was 69 years. Israel had no upper age
limit for recruitment; however, only subjects aged 30 to
69 years were included from this country in these analyses.
Population controls were frequency or individually matched
to cases by sex, age (within 5 years) and center. The sam-
pling frame for population controls differed from center to
center. Each of the following was used in at least one cen-
ter: electoral list, population registry, random digit dialing,
general practice patient lists and national health insurance
plan lists. When possible, a face-to-face interview with the
study subjects was conducted by a trained interviewer using
a computer-assisted questionnaire. When the study subject
had died or was too ill to be interviewed, the interview was
conducted with a proxy respondent, usually the spouse, but
occasionally an offspring. While this occurred not infre-
quently among cases, it occurred rarely among controls
when the control was selected from the sampling frame,
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information was collected on socio-demographic character-
istics, lifetime use of mobile phones and medical history.
Details of each center’s study methods are described else-
where [8,28].
In addition to the core questionnaire, a subset of
INTERPHONE study investigators had agreed to include
in the interview questionnaire a module to elicit a de-
tailed lifetime job history, and to participate in an ana-
lysis of occupational risk factors.
All participating study centres obtained the appropri-
ate Institutional Review Board authorisations. Written
informed consent for participation in the study was
obtained from all participants.
The INTEROCC study
The detailed occupational history module was used in
seven of the INTERPHONE countries (Australia, Canada,
France, Germany, Israel, New Zealand and the UK), and
the subjects in those countries comprise the INTEROCC
study subjects.
The lifetime work history requested information for all
jobs held by participants for more than 6 months, and
included job title, description of tasks, company name, de-
scription of activities of the company, and the start and
end year for each job. Each job held by subjects was coded
according to international occupation and industry classi-
fications: the International Standard Classification of Oc-
cupations editions 1968 (ISCO68) [31] and 1988 (ISCO88)
[32], and the International Standard Industrial Classifica-
tion of All Economic Activities, revision 2 (ISIC71) [33].
Common coding guidelines were provided to each center
in order to ensure homogeneity in the coding. An inter-
rater trial was conducted at the start of coding and results
were discussed with each center in a further effort to en-
sure consistency of coding [34].
Occupational exposure assessment
Occupational exposure to the agents was assessed using
a modified version of the Finnish job exposure matrix
FINJEM [29]. Based on the Finnish occupation classifi-
cation system containing 311 major occupational groups
and covering the calendar period from 1945 to 2003 di-
vided into several sub-periods, FINJEM can translate an
occupational history into a history of exposure to about
90 chemical, physical, behavioral, microbiological, ergo-
nomic and psychosocial factors, including the 10 agents
under investigation in this paper. FINJEM provides two
exposure estimates for each combination of occupation,
calendar sub-period, and agent: the proportion of wor-
kers in that occupation who were considered to be ex-
posed to the agent (P) and the mean level of exposure
among the exposed (L) expressed in concentration units.
When P was considered to be less than 5%, the level inFINJEM was set to zero. The estimates of P and L were
based on exposure measurements, hazard surveys, and
the judgements by Finnish occupational hygienists. The
fraction of daily or weekly worktime during which the
worker is thought to be exposed to the agent is implicitly
taken into account because L was constructed as a time-
weighted average. All 10 agents considered in this paper are
dusts or gases or fumes that entailed respiratory exposure.
Since FINJEM uses the Finnish occupational coding
system and the INTEROCC work histories were coded
according to international classifications, it was necessary
to develop a “crosswalk” between the Finnish codes and
the ISCO68. Furthermore, for our purposes, FINJEM was
modified in three ways [35].
First, the time window 1960–1984 was split into pre
and post-1974 periods, and some specific FINJEM en-
tries were modified for some of the agents of interest in
order to increase consistency and specificity of exposure
assessment. Second, exposure to benzo(a)pyrene was
modified to include exposure to environmental tobacco
smoke in the workplace. Third, meetings were held with
occupational exposure experts from the different centers
in order to consider possible differences in the meaning
of different job titles across countries and to consider
possible occupations and industries where the FINJEM
might not be generalizable to other countries. The resulting
changes were embodied in a revised version of FINJEM
that we call INTEROCC JEM [35].
Statistical methods
In this article, we are focusing on glioma only. All
interviewed controls in the seven INTEROCC countries
were used in these analyses, including those recruited
for meningioma cases in the centers which used individ-
ual matching.
For each agent, three exposure indices were defined for
the main analysis: i) ever vs. never; ii) lifetime cumulative
exposure; and iii) total duration of exposure. As noted
above, for each job, the INTEROCC JEM provides the
probability (P) that a worker in that occupation was
exposed to that agent. There are several approaches for
deriving an “ever exposure” variable from the INTEROCC
JEM. If we include in the definition all those who had a P
greater than 5%, it would be very sensitive but most of the
subjects labelled as exposed would have had a low prob-
ability of exposure. At the other extreme, if we define a
high threshold, say 95%, then it would be very specific, but
a large fraction of workers truly exposed would be labelled
as unexposed. The trade-off between sensitivity and speci-
ficity also has implications for the estimated prevalence of
exposure. In order to give greater weight to sensitivity
than specificity, but not to exaggerate this choice unduly,
we used as the a priori threshold P ≥ 25%. Thus, ever
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least one job with a probability of exposure of at least 25%
and for at least one year. Subjects who had held jobs with
a probability of exposure of less than 25% but greater than
5%, or for less than one year were considered to be of “un-
certain” exposure status and were not included in the ana-
lyses. The lifetime cumulative exposure index was defined
among ever exposed (corresponding to the ever definition
criteria) as the sum of the product of the probability of
exposure (P), the level of exposure (L) and the duration
for each job held by a subject. The continuous cumulative
exposure index was categorized according to tertiles of
the distribution among exposed controls. The total dur-
ation of exposure was defined as the sum of the duration
of exposure for each job held by a subject (corresponding
to the ever definition criteria) minus the possible overlap
period between two jobs. The total duration of exposure
was also categorized, but categories were defined a priori:
1–4 years, 5–9 years, and 10 or more years of exposure.
To allow sufficient time between occupational exposure
and disease initiation, all exposures that had occurred
within five years of the reference date (age at diagnosis for
cases and age at interview for controls) were not taken
into account, therefore establishing a lag period of 5 years.
For all analyses, the reference category included subjects
who had never been exposed to the specific chemical agent
of interest, e.g. subjects never exposed or exposed with a
probability lower than 5%. Because of the exploratory na-
ture of these analyses, each chemical agent was considered
independently of exposure to other agents. That is, the
possibility of mutual confounding among these agents was
ignored.
Associations between glioma and each of the 10 chem-
ical agents were estimated using conditional logistic re-
gression stratified by sex, age (5-year categories) and
center. Further, all analyses were a priori adjusted for
the following variables: i) age as a continuous variable
(in order to remove any residual confounding due to age
in the strata definition), ii) the maximum education level
attained by the subject or her/his spouse (primary, inter-
mediate college, tertiary), iii) the Standard International
Occupational Prestige Scale (SIOPS) [36], iv) history of
atopy, defined as ever diagnosed with allergy, asthma
and/or eczema (recognized as associated with glioma)
[37,38], and v) the respondent status (subject himself vs.
proxy respondent). Education level and SIOPS provide
two different measures of socio-economic status.
Missing values for the maximum level of education
attained in the household were imputed to the middle cat-
egory “intermediate college” (14 subjects). Missing values
for the SIOPS variable were imputed to the median value
in the corresponding subject strata of age (5-year categor-
ies), sex, center and maximum level of education attained
in the household (104 subjects).Sensitivity analyses
Our definition of “ever exposed” embodied a priori deci-
sions about probability of exposure (P ≥ 25%), duration
(D ≥ 1 year), and lag period (5 years). To evaluate the
sensitivity of results to these decisions, we tried different
thresholds. For probability of exposure, we implemented
thresholds of 5%, 25% (default) and 50%. For duration,
we implemented thresholds of 1 year (default) and 5 years.
Finally, for lag period, we implemented thresholds of
1 year, 5 years (default) and 10 years. Altogether there
were 18 combinations (3×2×3), including the main de-
fault combination.
In addition to the 17 sensitivity analyses embodied in
those alternative definitions of ever exposure, additional
sensitivity analyses were conducted: i) among males and
females separately; ii) restricting cases to the subset of
glioblastoma cases, iii) restricting the study sample to
those who responded for themselves (i.e. excluding pro-
xies), iv) including two additional a priori confounders
in each model: smoking status (ever, ex, never smokers)
and marital status (married vs. others); v) excluding each
of the a priori confounders from the default model;
vi) excluding subjects with missing values, instead of im-
puting values; vii) for benzo(a)pyrene (which had a high
proportion of subjects in the uncertain category), expos-
ure assessment according to the original version of
FINJEM, which excluded benzo(a)pyrene exposure from
environmental tobacco smoke [29].
Results
Of the eligible subjects who completed the interview, 54
cases and 36 controls were removed from the analyses
because it was technically impossible to link part of their
occupational history to the INTEROCC JEM. An additional
set of 9 cases and 6 controls were removed due to a family
history of neurofibromatosis and/or tuberous sclerosis.
Following these removals, the study sample consisted of
1,800 glioma cases and 5,160 controls. Response rates for
cases and controls were 68% and 50%, respectively.
Table 1 describes the main characteristics of subjects in-
cluded in the analysis. Germany, Israel, UK, and Australia
are the main contributor countries in terms of number of
glioma cases, accounting for more than 80% of the total.
The interviews were conducted with proxy respondents
for 14% of the cases and less than 1% of the controls. The
distribution of medical history of atopic conditions, smok-
ing, marital status, education level, and mean values for
SIOPS were similar among cases and controls.
Table 2 shows the main results for each of the 10 agents
analysed, using the a priori cut-point definition of ever
exposure: P ≥ 25%, duration ≥ 1 year; lag period of 5 years.
Subjects whose exposure probability was greater than 5%
but less than 25% were removed from the analysis (num-
ber of removed subjects varied by agent).
Table 1 Main characteristics of glioma cases and controls





n % n %
Country
Australia 277 15.4 665 12.9
Canada 169 9.4 649 12.6
France 93 5.2 471 9.1
Germany 366 20.3 1494 29.0
Israel 282 15.7 698 13.5
New Zealand 75 4.2 160 3.1
United Kingdom 538 29.9 1023 19.8
Sex
Males 1116 62.0 2308 44.7
Females 684 38.0 2852 55.3
Age (years)
30-39 328 18.2 791 15.3
40-49 460 25.6 1388 26.9
50-59 678 37.7 2022 39.2
60-69 334 18.6 959 18.6
Interview type
Self respondent 1543 85.7 5137 99.6
Proxy respondent 257 14.3 23 0.4
Atopya
Yes 416 23.1 1380 26.7
No 1384 76.9 3780 73.3
Smoking status
Current 508 28.2 1427 27.7
Ex 386 21.4 1212 23.5
Never 906 50.3 2521 48.9
Marital Status
Married 1422 79.0 4035 78.2
Single, divorced or widowed 363 20.2 1115 21.6
Unknown 15 0.8 10 0.2
Maximum level of education attained
Primary, secondary 766 42.6 2253 43.7
Intermediate college 382 21.2 1080 20.9
Tertiary 643 35.7 1822 35.3
Unknown 9 0.5 5 0.1
a Atopy: any medical history of allergy, asthma and/or eczema.
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Lifetime prevalence of exposure to benzo(a)pyrene,
diesel exhaust emissions and gasoline exhaust emissions
ranged from 8% to 20%. In all cases, prevalence of
exposure was much higher for males than females (data
not shown).The patterns of results were similar for the three com-
bustion products. There was no indication of excess risk
when analysing ever/never exposure status, and there
were no clear dose–response patterns, although the top
category of duration to diesel exhaust emissions did mani-
fest a borderline significant OR of 1.3 (95% CI: 1.0-1.8).
We observed generally similar results in all sensitivity
analyses, with slight variations in some (data not shown).
Dusts
The lifetime prevalence of exposure ranged from 4% for
wood dust to 16% for asbestos, with intermediate preva-
lences for crystalline silica and animal dust. As expected,
prevalences were much higher for males than females.
None of these agents manifested any association with
gliomas, neither in the ever/never analyses, nor in the
dose–response analyses, with either cumulative exposure
or duration. All sensitivity analyses gave similar results
(data not shown).
Other chemical agents
Prevalence of exposure ranged from 0.4% for sulphur di-
oxide to 3.5% for oil mist to 5.5% for formaldehyde.
Prevalences were much higher for males than females.
ORs for glioma amongst ever exposed compared to
never exposed were around 1.0 for both formaldehyde
and oil mist, and there were no indications of higher risk
in the higher categories of cumulative exposure or dur-
ation. For sulphur dioxide, the least prevalent of the 10
agents analysed (thus providing the most imprecise esti-
mates), the OR of glioma for ever exposure was 2.0 (95%
CI: 1.0-3.8), but the excess risk was concentrated in the
lowest tertile category of cumulative exposure and the
lowest duration category.
All sensitivity analyses gave similar results to those
presented in Table 2 (data not shown).
To explore whether the borderline significant result
regarding sulphur dioxide was in fact reflecting a clearer
excess risk in some subset of workers who incurred their
exposures in particular occupations or industries, we
reviewed the list of jobs of each subject ever exposed to
sulphur dioxide. There was no perceptible difference be-
tween cases and controls in the distributions of indus-
tries and occupations leading to sulphur dioxide
exposure. Most of these were in the iron and steel indus-
try. This exploration did not reveal any noteworthy clus-
ter of cases in any particular occupation or industry.
Since a borderline significant OR was also observed for
one of the subcategories of diesel exhaust emissions, we
also examined the lists of jobs of subjects ever exposed
to diesel exhaust emissions. There were no discernible
differences in occupational profiles between cases and
controls, with motor vehicle drivers or mechanics
representing the main occupations with diesel exhaust
Table 2 Association between 10 occupational agents and glioma in the seven-country INTEROCC study – five year lag
period
Formaldehyde Oil mist
Cases (1,800) Controls (5,160) OR d 95% CI Cases (1,800) Controls (5,160) OR 95% CI
n % c n % n % n %
Non exposed 1586 88.1 4639 89.9 1.0 - 1657 92.1 4810 93.2 1.0 -
Ever exposed a 96 5.3 283 5.5 0.8 0.6-1.1 63 3.5 151 2.9 0.8 0.6-1.1
Cumulative exposureb
Lowest tertile 32 1.8 99 1.9 0.9 0.6-1.3 12 0.7 50 1.0 0.5 0.3-1.0
Middle tertile 28 1.6 88 1.7 0.8 0.5-1.4 24 1.3 49 0.9 1.0 0.6-1.7
Highest tertile 34 1.9 94 1.8 0.7 0.5-1.1 23 1.3 50 1.0 0.9 0.5-1.6
Duration (years)
1 - 4 28 1.6 106 2.1 0.7 0.5-1.1 14 0.8 52 1.0 0.5 0.3-0.9
5 - 9 22 1.2 85 1.6 0.6 0.4-1.1 22 1.2 47 0.9 1.1 0.6-1.8
≥ 10 44 2.4 90 1.7 1.1 0.7-1.7 23 1.3 50 1.0 0.9 0.5-1.6
Diesel exhaust emissions Gasoline exhaust emissions
Non exposed 1458 81.0 4446 86.2 1.0 - 1558 86.6 4654 90.2 1.0 -
Ever exposed a 201 11.2 427 8.3 1.0 0.8-1.2 191 10.6 415 8.0 1.0 0.8-1.2
Cumulative exposureb
Lowest tertile 47 2.6 140 2.7 0.7 0.5-1.0 48 2.7 135 2.6 0.8 0.5-1.1
Middle tertile 73 4.1 139 2.7 1.2 0.9-1.7 68 3.8 135 2.6 1.1 0.8-1.5
Highest tertile 77 4.3 143 2.8 1.1 0.8-1.5 71 3.9 139 2.7 1.0 0.7-1.4
Duration (years)
1 - 4 57 3.2 153 3.0 0.8 0.6-1.2 51 2.8 135 2.6 0.8 0.6-1.2
5 - 9 55 3.1 126 2.4 0.9 0.6-1.2 56 3.1 137 2.7 0.8 0.6-1.2
≥ 10 85 4.7 143 2.8 1.3 1.0-1.8 80 4.4 137 2.7 1.3 0.9-1.8
Benzo(a)pyrene Sulphur dioxide
Non exposed 221 12.3 667 12.9 1.0 - 1775 98.6 5124 99.3 1.0 -
Ever exposed a 367 20.4 1056 20.5 0.8 0.6-1.0 20 1.1 19 0.4 2.0 1.0-3.8
Cumulative exposure b
Lowest tertile 94 5.2 344 6.7 0.7 0.5-0.9 11 0.6 7 0.1 3.1 1.2-8.5
Middle tertile 118 6.6 344 6.7 0.8 0.6-1.1 3 0.2 6 0.1 1.2 0.3-5.0
Highest tertile 149 8.3 353 6.8 0.9 0.7-1.2 6 0.3 6 0.1 1.4 0.4-4.7
Duration (years)
1 - 4 99 5.5 383 7.4 0.6 0.5-0.9 15 0.8 7 0.1 4.4 1.7-11.2
5 - 9 126 7.0 305 5.9 1.0 0.8-1.4 2 0.1 6 0.1 0.3 0.0-2.2
≥ 10 136 7.6 353 6.8 0.8 0.6-1.1 3 0.2 6 0.1 1.1 0.3-4.6
Asbestos Crystalline silica
Non exposed 1352 75.1 4204 81.5 1.0 - 1579 87.7 4712 91.3 1.0 -
Ever exposed a 292 16.2 621 12.0 0.9 0.8-1.1 200 11.1 413 8.0 1.0 0.8-1.2
Cumulative exposureb
Lowest tertile 89 4.9 210 4.1 0.8 0.6-1.1 54 3.0 135 2.6 0.8 0.3-1.2
Middle tertile 100 5.6 200 3.9 1.1 0.8-1.4 68 3.8 135 2.6 1.1 0.8-1.5
Highest tertile 103 5.7 211 4.1 1.0 0.7-1.3 74 4.1 138 2.7 1.1 0.8-1.5
Duration (years)
1 - 4 84 4.7 219 4.2 0.9 0.6-1.1 52 2.9 135 2.6 0.9 0.6-1.2
5 - 9 104 5.8 191 3.7 1.0 0.7-1.3 61 3.4 136 2.6 0.9 0.7-1.3
≥ 10 104 5.8 211 4.1 1.0 0.8-1.3 83 4.6 137 2.7 1.2 0.9-1.7
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Table 2 Association between 10 occupational agents and glioma in the seven-country INTEROCC study – five year lag
period (Continued)
Wood dust Animal dust
Non exposed 1706 94.8 4933 95.6 1.0 - 1733 96.3 5006 97.0 1.0 -
Ever exposed a 88 4.9 204 4.0 1.1 0.8-1.5 66 3.7 147 2.8 0.6 0.6-1.2
Cumulative exposureb
Lowest tertile 31 1.7 66 1.3 1.1 0.7-1.8 18 1.0 49 0.9 0.7 0.4-1.4
Middle tertile 31 1.7 66 1.3 1.1 0.7-1.8 24 1.3 49 0.9 0.9 0.5-1.5
Highest tertile 26 1.4 68 1.3 1.1 0.6-1.7 23 1.3 49 0.9 0.9 0.5-1.5
Duration (years)
1 - 4 32 1.8 69 1.3 1.1 0.7-1.7 25 1.4 55 1.1 0.8 0.4-1.5
5 - 9 27 1.5 63 1.2 1.1 0.7-1.8 17 0.9 43 0.8 0.9 0.5-1.6
≥ 10 29 1.6 68 1.3 1.1 0.7-1.8 23 1.3 49 0.9 0.8 0.4-1.4
a Probability of exposure in the modified version of FINJEM ≥ 25%; duration ≥ 1 year; lag period of 5 years.
b Calculated among exposed subject as ∑Probability × Level × Duration of each job held by a subject; cut-points at tertiles among exposed controls; expressed in
mg/m3 (oil mist, diesel and gasoline exhaust emissions, crystalline silica, wood dust and animal dust); ppm (formaldehyde, sulphur dioxide); μg/ m3 (benzo(a)
pyrene) or in fibers/m3 (asbestos).
c Percentages may not add up to 100 due to the exclusion of subjects classified as having ‘uncertain’ exposure.
d Odds ratios stratified by sex, age (5-year categories) and center and adjusted for age as a continuous variable, the maximum education level attained in the
household, the standard international occupational prestige scale, atopy and the respondent status.
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cluster of cases.
All sensitivity analyses are available from the corre-
sponding author upon request.
Discussion
We believe INTEROCC is the largest study ever con-
ducted on occupational chemical exposure and risk of
glioma. We examined the association between glioma
and 10 different chemical agents using three different
exposure indices. A large number of sensitivity analyses
were conducted, varying the definition of exposure as
derived from the INTEROCC JEM, covariates and other
analytic tactics and stratifying on the nature of the
tumor, sex of subjects, respondent status (self/proxy).
Considering all the sensitivity analyses, we analyzed over
200 different models for each chemical agent and thus
more than 2,000 models in total. Despite the large sam-
ple size, none of the 10 agents demonstrated a pattern of
findings that would be persuasive of a causal association
with glioma. The handful that were borderline statisti-
cally significant could most likely be attributed to mul-
tiple testing and random chance.
Although there have been few previous studies on occu-
pational risk factors for glioma, in particular, there have
been many previous studies on possible associations
between brain cancer and occupational circumstances.
However, most of these studies have suffered from some
combination of low statistical power due to few study sub-
jects combined with rare exposures, and inadequate assess-
ment of occupational exposures. While there have been no
consistently and persuasively reported associations, thereare a few leads that deserve attention and that have moti-
vated the present analyses.
There have been some reports of possible excess risks
of brain cancer among anatomists, pathologists and em-
balmers [23-25] and this has led to hypotheses regarding
a possible role for formaldehyde. But other studies of
formaldehyde-exposed workers have failed to support an
etiologic association between formaldehyde and brain
cancer [39-42]. Our results also failed to support such
an association.
While there have been some reports linking PAH expo-
sure to brain cancer risk [43,44], such an association was
not observed in all studies [45]. In our study, we focused
specifically on benzo(a)pyrene, and our results do not sup-
port a possible role of such exposure in the aetiology of
gliomas. Still, exposure to PAHs is ubiquitous, occurring
in many different occupations and industries, and often in
environments where workers are simultaneously exposed
to many other agents. Thus, analysing the specific role of
PAHs is challenging.
Whereas some previous results suggested a possible
increase of brain cancer risk among subjects exposed to
wood dust [15,46-48], two large studies, one a cohort
study [49] and the other a large international multi-center
case–control study [50], failed to detect any risk. In our
study, we did not find any association between glioma and
wood dust.
For diesel exhaust emissions and gasoline exhaust
emissions, an increased risk of brain cancer has been
reported among subjects employed as motor vehicle op-
erators [17,51], but our results did not support such an
association. The borderline significant OR for one subset
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random chance since we did not observe any excess
risks in relation to cumulative exposure.
An association between asbestos exposure and brain
cancer risk has been suggested by some studies [47,52],
but other investigations, including a recent large multi-
center case–control study of brain tumors in adults, did
not find any association between gliomas and asbestos
or insulation products in both men and women [50].
These findings are in agreement with our results, with
ORs near the null.
There has not been previous research on sulphur diox-
ide in relation to glioma. While we found a borderline
statistically significant OR between sulphur dioxide, the
least prevalent of the 10 agents, and glioma, this was
due to an excess of cases with very short duration, and it
is likely to be explained by random variability.
Finally, previous evidence for an association between
occupational exposure to oil products and/or animal
products and glioma is sparse and inconclusive [43,50],
and our results fail to support any such association.
Participation rates were 68% among glioma cases and
50% among controls. While these rates are not atypical
for contemporary population-based case–control stu-
dies, they are low enough to raise concerns about a
potential participation bias. This issue has been explored
in some depth in the parent INTERPHONE study with
regard to mobile phone use and brain cancer [53], and it
was estimated that differential participation rates could
those estimated ORs by 10% to 15%. Such biases, related
to the differential cellphone usage of participants vs.
non-participants, are unlikely to be applicable to the
present analyses of occupational exposures because
whereas cellphone usage is a prevalent behavioural
characteristic that might conceivably be related to the
behaviour of being willing and available to participate in
a study, it is less likely that being exposed to chemicals
at work is similarly correlated with study participation.
Even if there was a bias in the same order of magnitude,
it would hardly change the overall inferences of the
present analysis, as the ORs are far from being statisti-
cally elevated.
The only solidly established risk factors for glioma are
rare (ionizing radiation, rare medical conditions), probably
rarer than the agents that we are examining. Also, these
risk factors are probably not strongly correlated with the
agents we are examining. These conditions militate
against the likelihood that there was confounding of our
results by known risk factors. Further, since our observed
ORs were mainly around the null value, if confounding
had occurred it would have distorted a true causal associ-
ation to a null one, and this would require quite strong
negative correlation between the known risk factor(s) and
the agents that we are examining. Since there has beensome debate about the possible association between socio-
economic status and brain cancer risk [13,26,45,54,55], we
adjusted all results for socioeconomic status using two
different markers, one based on the Standard International
Occupational Prestige Scale and another one based on the
maximum level of education attained in the household. In
some sensitivity analyses, we also adjusted for marital
status (married vs. other) and this additional adjustment
did not change results. While it is theoretically possible
that our essentially null findings were biased by other
unmeasured confounders, this seems unlikely, as such fac-
tors would have to be quite strongly negatively associated
with the occupational agents we examined, conditional on
the socio-economic factors we did adjust for.
The exposure assessment was based on the subjects’
reported job histories, complemented by the data in
the INTEROCC JEM. The assessments did not rely on
self-reports of exposures, which have been shown to be
unreliable [56]. Besides the advantage of providing occu-
pational exposure assessments quickly and with modest
cost, especially considering the large number of study
subjects that had to be evaluated (approximatively 7,000
subjects), the use of a JEM has the advantage of provid-
ing a standardized tool to assign exposure and thereby
minimizing the possibility of recall and reporting bias.
On the other hand, a JEM allocates the same exposure
estimate to each subject in a given occupation in a given
era, without taking into account inter-individual variabil-
ity in performed tasks and job environments. The error
involved in applying a JEM is non-differential with re-
spect to case/control status and therefore can lead to
some attenuation of true odds ratios [57]. Furthermore,
in implementing the INTEROCC JEM, we had to deal
with values of probability of exposure ranging from 0%
to 100%. It was not self-evident how to use this informa-
tion in developing an index of exposure for our study.
We decided to create an ever/never exposed variable by
dichotomising the continuous probability entries at 25%
probability of exposure as assessed by the INTEROCC
JEM. Such a decision, favouring sensitivity over specifi-
city, is debatable and can lead to further exposure mis-
classification [58]. In sensitivity analyses, we used 5%
and 50% as alternative cut-points, and the results were
almost identical. Higher values of the cut-point were im-
practical since the number of subjects considered ex-
posed would be too low to sustain valid meaningful
analyses.
A final source of uncertainty and error relates to the
generalizability of the exposure profiles from Finland to
other countries. There must surely be some variability
between countries in the exposures of workers. Firstly,
the industrial profiles differ between different countries.
But this in itself is not a source of error in our study.
What would cause error is the fact that even within a
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experience different exposures. All of the countries in
INTEROCC have modern industrial economies where, a
priori, we would not expect industrial processes to be
radically different within occupations as would be the
case if we were comparing countries at very different
levels of industrialisation. Two comparisons have been
carried out between FINJEM estimates and those de-
rived by local experts, one in Australia [59] based on a
set of exposure agents that were not part of the present
analysis, and one in Canada [60], based on a set of
exposures that included those analysed here. Both com-
parisons demonstrated varying degrees of concordance
between exposure estimates derived from FINJEM com-
pared with those provided by local experts. For some
agents there was high concordance, while for other
agents, the concordance was rather low. An indirect in-
dication that our results were not compromised by
inter-country patterns of exposure in relation to occupa-
tions is the fact that when we carried out analyses within
countries, the results were the same as when we com-
bined countries (data not shown).
Statistical power to detect risks was limited by the low
prevalence of exposure for some agents, by the measure-
ment error inherent in our exposure assessment, and by
the fact that many of the exposed subjects may have ex-
perienced relatively low concentrations of exposure.
Thus, the essentially null results presented here should
not be interpreted as strong evidence for an absence of
any risk. Still, this is the strongest evidence to date on
glioma risks from these agents.
Conclusion
This is the largest study to date to investigate associations
between selected occupational exposures and glioma. Our
findings do not support an association between any of the
chemical agents examined and risk of glioma.
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